default author photo

Thais Maloberti

Alma Mater Studiorum University of Bologna

Bologna

Italy

  • Alma Mater Studiorum University of Bologna

SCHOLARLY PAPERS

1

DOWNLOADS

53

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Stk11 Mutations Predict Poor Prognosis for Advanced Nsclc Treated with First-Line Immunotherapy or Chemo-Immunotherapy According to Kras, Tp53, Keap1, and Smarca4 Status

Number of pages: 18 Posted: 10 Jul 2024
Andrea De Giglio, Dario De Biase, Valentina Favorito, Thais Maloberti, Alessandro Di Federico, Federico Zacchini, Giulia Venturi, Claudia Parisi, Filippo Gustavo Dall’Olio, Ilaria Ricciotti, Ambrogio Gagliano, Barbara Melotti, Francesca Sperandi, Annalisa Altimari, Elisa Gruppioni, Giovanni Tallini, Francesco Gelsomino, Lorenzo Montanaro and Andrea Ardizzoni
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Alma Mater Studiorum University of Bologna, Alma Mater Studiorum University of Bologna, Alma Mater Studiorum University of Bologna, Alma Mater Studiorum University of Bologna, Alma Mater Studiorum University of Bologna, Alma Mater Studiorum University of Bologna, affiliation not provided to SSRN, affiliation not provided to SSRN, Alma Mater Studiorum University of Bologna, Alma Mater Studiorum University of Bologna, Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, affiliation not provided to SSRN, affiliation not provided to SSRN, Alma Mater Studiorum University of Bologna, Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Alma Mater Studiorum University of Bologna and Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna
Downloads 53 (1,052,702)

Abstract:

Loading...

NSCLC, Immunotherapy, STK11, prognosis